Register now for our webinar ‘The European Drug Report: Using an open data approach to improve data visualisation’ | data.europa.eu
Pasar al contenido principal
European data
data.europa.eu
El portal oficial de datos europeos

Register now for our webinar ‘The European Drug Report: Using an open data approach to improve data visualisation’

Save the date for a discussion on improving data visualisation through open data usage

On 21 June from 10:00 to 11:30 CEST, join us for the webinar ‘The European Drug Report: using an open data approach to improve data visualisation’. In this engaging session, the report of the European Drug Agency will be presented, allowing you to learn from the latest experiences and insights. The webinar is suitable for public health professionals, policymakers, data enthusiasts, and anyone interested in leveraging open data to improve the clarity and impact of the European Drug Report

This webinar will explore how open data can be used to enhance the report's data visualisation, making complex information more accessible and actionable. You will learn about innovative data visualisation methods and gain insights with technical demonstrations of backend tools and the according implementation process. This session will also showcase how the European Drug Agency collaborated with urban journalism networks and how their data is visualised across Europe.

By attending this webinar, you will enhance your skills in data visualisation techniques and the transition of the European Drug Agency to an open data approach. You will have the opportunity to interact with like-minded participants, share your experience, and learn about the tools that will help you visualise open data and how to implement this in your own work. 

Register for a spot today and join us in the active discussion on using open data to improve data visualisation! If you already want to familiarise yourself with data visualisation, you can take a look at our visualisation guide, which has topics for every experience level. 

For more news and events, follow us on X/TwitterFacebook and LinkedIn, or subscribe to our newsletter.

Text of this article